Skip to content

Screening and application of molecular markers for the diagnosis of Rolandic epilepsy based on metabolomics of blood samples

Screening and application of molecular markers for the diagnosis of Rolandic epilepsy based on metabolomics of blood samples

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118994
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rolandic epilepsy (RE)

Interventions

Refractory variant Rolandic epilepsy:none
rolandic epilepsy:none
Variant Rolandic epilepsy:none
Healthy control group:none

Sponsors

Foshan Maternity & Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. According to the 2017 classification criteria of epilepsy and epileptic syndromes by the International League Against Epilepsy, the diagnosis was RE, ARE (with a sleep spike-wave index (SWI) >= 85% as the diagnostic criterion), and refractory ARE (with continued clinical seizure activity or SWI >= 85% after one year of drug treatment).

Exclusion criteria

Exclusion criteria: 1. Children with confirmed space-occupying lesions such as tumors and other neurodegenerative diseases through imaging studies; 2. Those with severe dysfunction of vital organs such as the heart, liver and kidneys; 3. Children with infections as indicated by blood and cerebrospinal fluid tests; 4. Those with systemic immune system diseases; 5. Those with congenital immune deficiencies; 6. Those with contraindications to the use of glucocorticoids.

Design outcomes

Primary

MeasureTime frame
Blood metabolomic profile (untargeted metabolomics),Differential metabolite identification and pathway enrichment analysis, Diagnostic biomarker panel;

Countries

China

Contacts

Public ContactDai Jiemin

Foshan Maternity & Child Healthcare Hospital

daijm6639@foxmail.com+86 757 8296 9871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026